14 drug(s) with this reaction
4,060 total reports
Covid 19 has been reported as an adverse reaction across 14 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 4,060 adverse event reports mention covid 19 in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with covid 19, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have covid 19 listed in their FDA adverse event reports, sorted by report count:
In addition to covid 19, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
14 drug(s) manufactured by Haleon Us Holdings Llc have covid 19 listed in their FDA adverse event reports: FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, IBUPROFEN SODIUM, IBUPROFEN TABLETS, COATED, ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE, and others.
There are a combined 4,060 reports of covid 19 across 14 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.